Tango Therapeutics' strong share price surge has led to a so...
Tango Therapeutics' strong share price surge has led to a soaring P/S, but forecasted future revenues may not support this high P/S ratio. With below-industry-average revenue growth predicted, caution is advised as this could potentially harm long-term share prices.
Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 25%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment